Drug class
Haemophilus B Vaccine
The Haemophilus B vaccine class comprises bacterial conjugate vaccines formulated for active immunization against invasive disease caused by *Haemophilus influenzae* type b. Read more about Haemophilus B Vaccine
14 drugs in this class 5 manufacturers
Drugs in Haemophilus B Vaccine
PENTACEL (diphtheria,pertussis(acell),tetanus,polio/Haemophilus B/PF)
HIBERIX (Haemophilus b conjugate vaccine(tetanus toxoid conjugate)/PF)
PENTACEL ACTHIB COMPONENT (Haemophilus b conjugate vaccine(tetanus toxoid conjugate)/PF)
PENTACEL ACTHIB COMPONENT (Haemophilus B polysacc conj-tetanus tox,component 2 of 2/PF)
VAXELIS (PF) (diphtheria,pertus(acell),tetanus/hepB/polio/Hib conj-meng/PF)
ACTHIB (PF) (Haemophilus b conjugate vaccine(tetanus toxoid conjugate)/PF)
PENTACEL (PF) (diphtheria,pertussis(acell),tetanus,polio/Haemophilus B/PF)
HIBERIX (PF) (Haemophilus b conjugate vaccine(tetanus toxoid conjugate)/PF)
The Haemophilus B vaccine class comprises bacterial conjugate vaccines formulated for active immunization against invasive disease caused by *Haemophilus influenzae* type b.
These biologics link the purified capsular polysaccharide polyribosylribitol phosphate to a carrier protein, such as tetanus toxoid or meningococcal outer membrane protein, converting a T-independent antigen into a T-dependent immune response that effectively stimulates protective bactericidal antibody production and immunologic memory.
Formulations in this class are primarily indicated for infants and young children to prevent life-threatening systemic infections, most notably bacterial meningitis, epiglottitis, bacteremia, pneumonia, and septic arthritis.
-
fda.gov
The Haemophilus B vaccine class comprises bacterial conjugate vaccines formulated for active immunization against invasive disease caused by *Haemophilus influenzae* type b
-
cdc.gov
The Haemophilus B vaccine class comprises bacterial conjugate vaccines formulated for active immunization against invasive disease caused by *Haemophilus influenzae* type b These biologics link the purified capsular polysaccharide polyribosylribitol phosphate to a carrier protein, such as tetanus toxoid or meningococcal outer membrane protein, converting a T-independent antigen into a T-dependent immune response that effectively stimulates protective bactericidal antibody production and immunolo...
-
fda.gov
These biologics link the purified capsular polysaccharide polyribosylribitol phosphate to a carrier protein, such as tetanus toxoid or meningococcal outer membrane protein, converting a T-independent antigen into a T-dependent immune response that effectively stimulates protective bactericidal antibody production and immunologic memory Formulations in this class are primarily indicated for infants and young children to prevent life-threatening systemic infections, most notably bacterial meningit...
-
fda.gov
Formulations in this class are primarily indicated for infants and young children to prevent life-threatening systemic infections, most notably bacterial meningitis, epiglottitis, bacteremia, pneumonia, and septic arthritis
-
mayoclinic.org
Formulations in this class are primarily indicated for infants and young children to prevent life-threatening systemic infections, most notably bacterial meningitis, epiglottitis, bacteremia, pneumonia, and septic arthritis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.